BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3246395)

  • 1. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.
    Gulati S; Marwaha RK; Dilawari JB; Midha U; Walia BN
    Indian Pediatr; 1992 Jan; 29(1):73-7. PubMed ID: 1601501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
    Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
    Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulation of the markers of the hepatitis B virus in different clinical forms of the disease].
    Frolov AF; Raksha EA; Nagornova TF; Vasilenko LG
    Vrach Delo; 1984 Apr; (4):108-11. PubMed ID: 6741040
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of time-resolved fluoroimmunoassay in the detection of HBV markers].
    Luo KZ; Yang X; Su XS; Xu Y; Li LY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):569. PubMed ID: 14552731
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological markers correlated with hepatitis B virus. Study made predominantly in chronic hepatitis in children].
    Calzia R; Ciravegna B; Navone C; Fiorini R; Tolentino P
    Minerva Pediatr; 1981 Aug; 33(16):805-15. PubMed ID: 6273707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Seroepidemiology of hepatitis B in pediatric age. Studies conducted in the city of Rome].
    Mastroeni I; Vescia N; Pompa MG; Signorelli C
    Ann Ig; 1990; 2(1-2):15-9. PubMed ID: 1711334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
    Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
    Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 13. Australia antigen (HBsAg) in thallassemia children receiving multiple transfusions.
    Mehta KP; Patil HL; Merchant SM; Babar ST; Baxi AJ; Bapat JP
    Indian Pediatr; 1977 Jun; 14(6):455-9. PubMed ID: 604273
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion associated hepatitis C in multi-transfused thalassemic children.
    Mishra D; Pensi T
    Indian Pediatr; 2004 Mar; 41(3):287-8. PubMed ID: 15064522
    [No Abstract]   [Full Text] [Related]  

  • 15. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B markers in children with oncological diseases].
    Mikhaĭlov MI; Papernova NIu; Zinov'eva LI; Durnov LA; Makhonova LA
    Vopr Onkol; 1986; 32(1):70-4. PubMed ID: 3946089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of IgM anti-HAV test in hepatitis evaluation (author's transl)].
    Iosa G; Turci F; Cipolloni AP; Cenciotti L
    Quad Sclavo Diagn; 1981 Sep; 17(3):289-93. PubMed ID: 7343983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Identification of the e-system and subtypes in 607 cases of HBsAg carriers].
    Kang RY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Dec; 4(6):329-30. PubMed ID: 6675854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk of posttransfusion hepatitis in hemophilia patients].
    Margolina AN; Somova AV; Golosova TV; Pliushch OP; Andreev IuN
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):46-8. PubMed ID: 7367412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.